Webinar – “COVID Vaccines and Antitrust Law”
Date: 24 of february of 2021
Time: 4:00 pm - 6:00 pm
Place: Plataforma Virtual Zoom
The Economic Law Department invites the academic community to the virtual discussion: “COVID Vaccines and Antitrust Law.”
To mitigate the profound social, economic, and political effects the COVID-19 pandemic has caused in the world, scientists and governments around the world developed, in record time, a vaccine against the virus. However, it is indisputable that the private sector’s investment in research and development (R&D) was vital for the vaccine to be developed in a relatively short period and with a high effectiveness percentage.
The first part of the discussion will analyze the tensions between the right to free enterprise and universal access to the vaccine. In the second part, the challenges generated by universal access to the vaccine will be analyzed from the Competition Law point of view, particularly those related to the restrictive assumptions generated in the purchase process of COVID vaccines, such as differential prices, confidentiality clauses, excessive profits, and discrimination among countries.
Rights’ Friction. Universal access to the vaccine and the right to free enterprise
- José Manuel Álvarez Zárate, Director, Economic Law Department (Moderator)
- Magdalena Correa Henao, Director, Constitutional Law Department
- Carlos Correa, Director of the South Center in Geneva, Switzerland
Analysis of the restrictive assumptions within the purchase of COVID vaccines: differential pricing, confidentiality clauses, excessive profits, and discrimination among countries
- David Toro Ochoa, professor of Economic Law, consulting attorney. (Moderator)
- Tatiana Samay Andia Rey, Director, Graduate School, Social Sciences Faculty, Universidad de los Andes
- Jorge Enrique Sánchez, former Competition Law Deputy Superintendent, Economic Law professor
- Mauricio Velandia Castro, Economic Law professor, consulting attorney
* The University reserves the right to modify the programming, topics, and speakers.